Position in ALKS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$17,504,011
-$53,702,149 QoQ
Shares Held
495,023
-80.5% QoQ
Ownership
0.297%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 79.33146540665787.ToString("F0")%
Shared 0.ToString("F0")%
None 20.668534593342127.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Derivatives in ALKS
reported options exposure · as of Sep 30, 2023CallValue
$7,643,929
CallShares
272,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026UBS Group AG holds $1,524,520,292 across 81 Drug Manufacturers - Specialty & Generic names. ALKS ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,799,543 | $330,933,975 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
8,572,057 | $205,129,322 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
1,221,036 | $160,859,281 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
236,729 | $140,375,559 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
4,151,638 | $86,188,003 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,192,264 | $66,820,205 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
867,675 | $65,813,148 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,877,217 | $56,541,775 |
All Filings in ALKS
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,504,011 | 495,023 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $71,206,160 | 2,544,895 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $22,624,980 | 754,166 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $38,406,120 | 1,342,402 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $100,486,760 | 3,043,209 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,201,042 | 319,925 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,202,655 | 507,419 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,249,541 | 466,786 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,170,840 | 412,665 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,538,537 | 271,757 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,755,186 | 134,066 | Shares | Defined | 2023-11-09 | |
| 2023-09-30 | $7,643,929 | 272,900 | Call | Defined | 2023-11-09 | |
| 2023-06-30 | $8,541,770 | 272,900 | Call | Defined | 2023-08-11 | |
| 2023-06-30 | $665,531 | 21,263 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $635,880 | 22,557 | Shares | Defined | 2023-05-12 | |
| 2023-03-31 | $7,693,051 | 272,900 | Call | Defined | 2023-05-12 | |
| 2022-12-31 | $520,352 | 19,914 | Shares | Defined | 2023-02-08 | |
| 2022-12-31 | $7,130,877 | 272,900 | Call | Defined | 2023-02-08 | |
| 2022-09-30 | $444,344 | 19,899 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $839,243 | 28,172 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $969,864 | 36,863 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $702,660 | 30,209 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $641,626 | 20,805 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,919,690 | 282,206 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $33,566,707 | 1,796,933 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $58,320,073 | 2,923,312 | Shares | Defined | 2021-02-11 | |
| 2020-06-30 | $38,060,797 | 1,960,886 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $5,497,826 | 381,264 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||